Literature DB >> 29694991

Bronchopulmonary Dysplasia: Can We Agree on a Definition?

Eduardo Bancalari1, Deepak Jain1.   

Abstract

The advances in obstetric and neonatal care over the last half century have resulted in changes in pathophysiology and clinical presentation of bronchopulmonary dysplasia (BPD). In contrast to the original description of BPD by Northway et al as a severe lung injury in relatively mature preterm infants, the most common form of BPD currently is characterized by chronic respiratory insufficiency in extremely preterm infants. This evolution in the presentation of BPD, along with changes in respiratory support strategies such as increased use of nasal cannula oxygen, has presented a unique challenge to find a definition that describes the severity of lung damage and predict the long-term respiratory outcomes with some accuracy.The limitations of current definitions of BPD include inconsistent correlation with long-term respiratory outcomes, inability to classify infants dying from severe respiratory failure prior to 36 weeks' postmenstrual age, and potential inappropriate categorization of infants on nasal cannula oxygen or with extrapulmonary causes of respiratory failure. In the long term, the aim for a new definition of BPD is to develop a classification based on the pathophysiology and objective lung function evaluation providing a more accurate assessment for individual patients. Until then, a consensus definition that encompasses current clinical practices, provides reasonable prediction of later respiratory outcomes, and is relatively simple to use should be achieved. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29694991     DOI: 10.1055/s-0038-1637761

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  13 in total

Review 1.  Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period.

Authors:  Marta Perez; Mary E Robbins; Cecilie Revhaug; Ola D Saugstad
Journal:  Free Radic Biol Med       Date:  2019-04-05       Impact factor: 7.376

2.  Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.

Authors:  Cristina Ramos-Navarro; Elena Maderuelo-Rodríguez; Ana Concheiro-Guisán; Santiago Pérez-Tarazona; Santiago Rueda-Esteban; Ana Sánchez-Torres; Manuel Sánchez-Solís; Ester Sanz-López; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2021-10-01       Impact factor: 3.183

3.  Sleep-disordered breathing symptoms and their association with structural and functional pulmonary changes in children born extremely preterm.

Authors:  Victoria Griffiths; Henrietta Blinder; Lamia Hayawi; Nicholas Barrowman; Thuy Mai Luu; Theo J Moraes; Grace Parraga; Giles Santyr; Bernard Thébaud; Anne-Monique Nuyt; Sherri L Katz
Journal:  Eur J Pediatr       Date:  2022-10-19       Impact factor: 3.860

4.  Knockdown of miR-203a-3p alleviates the development of bronchopulmonary dysplasia partly via the up-regulation of vascular endothelial growth factor A.

Authors:  Hanrong Cheng; Li Chen; Yongli Wei; Tianyong Hu; Dongcai Li; Benqing Wu
Journal:  J Bioenerg Biomembr       Date:  2021-01-07       Impact factor: 2.945

Review 5.  Predicting Long-Term Respiratory Outcomes in Premature Infants: Is It Time to Move beyond Bronchopulmonary Dysplasia?

Authors:  Deepak Jain; Alexander Feldman; Subhasri Sangam
Journal:  Children (Basel)       Date:  2020-12-10

Review 6.  Non-invasive Ventilation for Children With Chronic Lung Disease.

Authors:  Emine Atag; Uros Krivec; Refika Ersu
Journal:  Front Pediatr       Date:  2020-11-11       Impact factor: 3.418

7.  Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial.

Authors:  Yuan He; Yong Zhang; Shuqiang Gao; Xiaoling Wang; Na He; Deshuang Zhang; Wenbin Dong; Christian Wieg; Xiaoping Lei
Journal:  Trials       Date:  2020-09-03       Impact factor: 2.279

8.  Mechanism of oxidative stress and Keap-1/Nrf2 signaling pathway in bronchopulmonary dysplasia.

Authors:  Di Ma; Wenhui Gao; Junjiao Liu; Dan Kong; Yunfeng Zhang; Min Qian
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.817

9.  Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.

Authors:  Stephanie B Wall; Rachael Wood; Katelyn Dunigan; Qian Li; Rui Li; Lynette K Rogers; Trent E Tipple
Journal:  Oxid Med Cell Longev       Date:  2019-01-21       Impact factor: 6.543

10.  Late Administration of Surfactant May Increase the Risk of Patent Ductus Arteriosus.

Authors:  Fuat Emre Canpolat; Gülsüm Kadıoğlu Şimşek; James Webbe; Mehmet Büyüktiryaki; Nazmiye Bengü Karaçağlar; Sarkhan Elbayiyev; H Gözde Kanmaz Kutman
Journal:  Front Pediatr       Date:  2020-03-31       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.